NASDAQ:ALIM - Alimera Sciences Stock Price, Forecast & News

Alimera Sciences trades on the NASDAQ under the ticker symbol "ALIM."

Shares of Alimera Sciences reverse split on Friday, November 15th 2019. The 1-15 reverse split was announced on Thursday, November 7th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 14th 2019. An investor that had 100 shares of Alimera Sciences stock prior to the reverse split would have 7 shares after the split.

Alimera Sciences Inc (NASDAQ:ALIM) issued its quarterly earnings results on Tuesday, October, 29th. The biopharmaceutical company reported ($0.60) EPS for the quarter, meeting the Zacks' consensus estimate of ($0.60). The biopharmaceutical company earned $12.85 million during the quarter, compared to analysts' expectations of $12.75 million. View Alimera Sciences' Earnings History.

Alimera Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Alimera Sciences.

3 brokerages have issued twelve-month price targets for Alimera Sciences' stock. Their forecasts range from $15.00 to $45.00. On average, they anticipate Alimera Sciences' stock price to reach $30.00 in the next twelve months. This suggests a possible upside of 308.2% from the stock's current price. View Analyst Price Targets for Alimera Sciences.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alimera Sciences in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Alimera Sciences.

News articles about ALIM stock have trended somewhat negative recently, InfoTrie reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Alimera Sciences earned a news sentiment score of -1.0 on InfoTrie's scale. They also gave headlines about the biopharmaceutical company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Alimera Sciences.

Alimera Sciences saw a decrease in short interest during the month of December. As of December 31st, there was short interest totalling 74,100 shares, a decrease of 17.5% from the December 15th total of 89,800 shares. Based on an average daily trading volume, of 69,700 shares, the short-interest ratio is currently 1.1 days. Approximately 1.9% of the shares of the stock are short sold. View Alimera Sciences' Current Options Chain.

Some companies that are related to Alimera Sciences include Verastem (VSTM), AcelRx Pharmaceuticals (ACRX), Cassava Sciences (SAVA), vTv Therapeutics (VTVT), TapImmune (MRKR), Savara (SVRA), Helix Biopharma (HBPCF), Gemphire Therapeutics (GEMP), Sierra Oncology (SRRA), Newron Pharmaceuticals (NWPHF), REDHILL BIOPHAR/S (RDHL), CymaBay Therapeutics (CBAY), Zynerba Pharmaceuticals (ZYNE), Galmed Pharmaceuticals (GLMD) and ProMetic Life Sciences (PFSCF).

Based on aggregate information from My MarketBeat watchlists, some companies that other Alimera Sciences investors own include Eyepoint Pharmaceuticals (EYPT), NovaBay Pharmaceuticals (NBY), Agenus (AGEN), Opko Health (OPK), Amarin (AMRN), Catalyst Pharmaceuticals (CPRX), Novavax (NVAX), CorMedix (CRMD), Aldeyra Therapeutics (ALDX) and Athersys (ATHX).

Shares of ALIM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALIM stock can currently be purchased for approximately $7.35.

Alimera Sciences has a market capitalization of $36.53 million and generates $46.97 million in revenue each year. Alimera Sciences employs 124 workers across the globe.View Additional Information About Alimera Sciences.

The official website for Alimera Sciences is http://www.alimerasciences.com/.

Alimera Sciences' mailing address is 6120 WINDWARD PARKWAY STE 290, ALPHARETTA GA, 30005. The biopharmaceutical company can be reached via phone at 678-990-5740 or via email at [email protected]